These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 6220870

  • 1. Effects of treatment with erythromycin 1.5 percent topical solution or clindamycin phosphate 1.0 percent topical solution on P. acnes counts and free fatty acid levels.
    Puhvel SM.
    Cutis; 1983 Mar; 31(3):339-42. PubMed ID: 6220870
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of topical erythromycin and oral tetracycline in acne vulgaris.
    Rapaport M, Puhvel SM, Reisner RM.
    Cutis; 1982 Jul; 30(1):122-6, 130, 132-5. PubMed ID: 6214377
    [Abstract] [Full Text] [Related]

  • 3. Comparison of topical erythromycin 1.5 percent solution versus topical clindamycin phosphate 1.0 percent solution in the treatment of acne vulgaris.
    Thomas DR, Raimer S, Smith EB.
    Cutis; 1982 Jun; 29(6):624-5, 628-32. PubMed ID: 6213379
    [Abstract] [Full Text] [Related]

  • 4. Acne treatment with topical erythromycin and zinc: effect of Propionibacterium acnes and free fatty acid composition.
    Strauss JS, Stranieri AM.
    J Am Acad Dermatol; 1984 Jul; 11(1):86-9. PubMed ID: 6234335
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
    Cunliffe WJ, Holland KT, Bojar R, Levy SF.
    Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
    [Abstract] [Full Text] [Related]

  • 6. Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes.
    Leyden JJ.
    Cutis; 2002 Jun; 69(6):475-80. PubMed ID: 12078851
    [Abstract] [Full Text] [Related]

  • 7. Topical antibiotics and topical antimicrobial agents in acne therapy.
    Leyden JJ, McGinley K, Mills OH, Kligman AM.
    Acta Derm Venereol Suppl (Stockh); 1980 Jun; Suppl 89():75-82. PubMed ID: 6451130
    [No Abstract] [Full Text] [Related]

  • 8. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
    Kellett N, West F, Finlay AY.
    Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
    [Abstract] [Full Text] [Related]

  • 9. Topically applied antibiotics in acne vulgaris: clinical response and suppression of Corynebacterium acnes in open comedones.
    Resh W, Stoughton RB.
    Arch Dermatol; 1976 Feb; 112(2):182-4. PubMed ID: 134675
    [Abstract] [Full Text] [Related]

  • 10. A comparison of clindamycin phosphate 1 percent topical lotion and placebo in the treatment of acne vulgaris.
    Kuhlman DS, Callen JP.
    Cutis; 1986 Sep; 38(3):203-6. PubMed ID: 2945704
    [Abstract] [Full Text] [Related]

  • 11. [Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy].
    Abeck D.
    MMW Fortschr Med; 2003 Dec 18; 145(51-52):29. PubMed ID: 14974325
    [No Abstract] [Full Text] [Related]

  • 12. Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes.
    Gans EH, Kligman AM.
    J Dermatolog Treat; 2002 Sep 18; 13(3):107-10. PubMed ID: 12227872
    [Abstract] [Full Text] [Related]

  • 13. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
    Song M, Seo SH, Ko HC, Oh CK, Kwon KS, Chang CL, Kim MB.
    J Dermatol; 2011 Jul 18; 38(7):667-73. PubMed ID: 21352337
    [Abstract] [Full Text] [Related]

  • 14. Contribution to the interpretation of the occurrence of unsuccessful therapeutical results in acne vulgaris with topical erythromycin (Propionibact. acnes).
    Gloor M, Lamerz A, Franke-Hoffman M.
    Zentralbl Bakteriol A; 1981 Feb 18; 248(4):502-8. PubMed ID: 6452774
    [Abstract] [Full Text] [Related]

  • 15. Topical clindamycin treatment of acne. Clinical, surface lipid composition, and quantitative surface microbiology response.
    Thomsen RJ, Stranieri A, Knutson D, Strauss JS.
    Arch Dermatol; 1980 Sep 18; 116(9):1031-4. PubMed ID: 6448025
    [Abstract] [Full Text] [Related]

  • 16. [Bacterial resistance in acne? A meta-analysis of the controversy].
    Alvarez-Sánchez M, Rodríguez-Ayala E, Ponce-Olivera RM, Tirado-Sánchez A, Arellano-Mendoza MI.
    Cir Cir; 2016 Sep 18; 84(3):190-5. PubMed ID: 26738649
    [Abstract] [Full Text] [Related]

  • 17. A comparison of Cleocin T 1 percent solution and Cleocin T 1 percent lotion in the treatment of acne vulgaris.
    Goltz RW, Coryell GM, Schnieders JR, Neidert GL.
    Cutis; 1985 Sep 18; 36(3):265-8. PubMed ID: 2932307
    [Abstract] [Full Text] [Related]

  • 18. Effects of topical erythromycin on aerobic and anaerobic surface flora.
    Bernstein JE, Shalita AR.
    Acta Derm Venereol; 1980 Sep 18; 60(6):537-9. PubMed ID: 6162344
    [Abstract] [Full Text] [Related]

  • 19. In vivo antibacterial effects of tretinoin-clindamycin and clindamycin alone on Propionibacterium acnes with varying clindamycin minimum inhibitory.
    Leyden JJ.
    J Drugs Dermatol; 2012 Dec 18; 11(12):1434-8. PubMed ID: 23377513
    [Abstract] [Full Text] [Related]

  • 20. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study.
    Dreno B, Foulc P, Reynaud A, Moyse D, Habert H, Richet H.
    Eur J Dermatol; 2005 Dec 18; 15(3):152-5. PubMed ID: 15908296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.